Akero Therapeutics Inc (NASDAQ: AKRO) closed the day trading at $27.23 down -0.26% from the previous closing price of $27.30. In other words, the price has decreased by -$0.07 from its previous closing price. On the day, 843073 shares were traded.
Ratios:
For a better understanding of AKRO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 20.25 and its Current Ratio is at 20.25. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on September 19, 2023, initiated with a Overweight rating and assigned the stock a target price of $69.
On August 28, 2023, UBS started tracking the stock assigning a Buy rating and target price of $83.
Morgan Stanley Upgraded its Equal-Weight to Overweight on January 27, 2023, whereas the target price for the stock was revised from $40 to $65.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 27 when Young Jonathan sold 5,414 shares for $24.00 per share. The transaction valued at 129,936 led to the insider holds 185,131 shares of the business.
Cheng Andrew sold 1,628 shares of AKRO for $33,797 on Dec 14. The President and CEO now owns 550,911 shares after completing the transaction at $20.76 per share. On Dec 14, another insider, White William Richard, who serves as the Chief Financial Officer of the company, sold 611 shares for $20.76 each. As a result, the insider received 12,684 and left with 50,354 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKRO now has a Market Capitalization of 1.52B and an Enterprise Value of 988.48M.
Stock Price History:
Over the past 52 weeks, AKRO has reached a high of $58.38, while it has fallen to a 52-week low of $11.25. The 50-Day Moving Average of the stock is 22.28, while the 200-Day Moving Average is calculated to be 33.70.
Shares Statistics:
Over the past 3-months, AKRO traded about 1.11M shares per day on average, while over the past 10 days, AKRO traded about 1.17M shares per day. A total of 55.71M shares are outstanding, with a floating share count of 47.91M. Insiders hold about 14.00% of the company’s shares, while institutions hold 102.55% stake in the company. Shares short for AKRO as of Feb 15, 2024 were 8.89M with a Short Ratio of 8.01, compared to 7.6M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 15.97% and a Short% of Float of 16.40%.
Earnings Estimates
Current recommendations for the stock of the company come from 8 analysts. On average, analysts expect EPS of -$0.86 for the current quarter, with a high estimate of -$0.67 and a low estimate of -$1.09, while EPS last year was -$0.49. The consensus estimate for the next quarter is -$0.9, with high estimates of -$0.79 and low estimates of -$0.99.
Analysts are recommending an EPS of between -$2.66 and -$3.12 for the fiscal current year, implying an average EPS of -$2.84. EPS for the following year is -$3.53, with 8 analysts recommending between -$2.79 and -$4.29.
